DRUG · Unmapped registry intervention
SAM-315
Find medicine records ·
Find other trials using this name
Clinical trial
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315
NCT00474552
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer Diseaseverified · MONDO: Alzheimer disease
Interventions
SAM-315DRUG
Sponsors & collaborators
Wyeth is now a wholly owned subsidiary of Pfizerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00474552 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.